La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Compumedics Résultats passés
Passé contrôle des critères 1/6
Compumedics's earnings have been declining at an average annual rate of -38.2%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 2.7% per year. Compumedics's return on equity is 6.8%, and it has net margins of 2.5%.
Informations clés
-38.2%
Taux de croissance des bénéfices
-38.0%
Taux de croissance du BPA
Medical Equipment Croissance de l'industrie | 5.8% |
Taux de croissance des recettes | 2.7% |
Rendement des fonds propres | 6.8% |
Marge nette | 2.5% |
Dernière mise à jour des bénéfices | 31 Dec 2023 |
Mises à jour récentes des performances passées
Recent updates
Further Upside For Compumedics Limited (ASX:CMP) Shares Could Introduce Price Risks After 38% Bounce
Jun 17Returns On Capital Signal Difficult Times Ahead For Compumedics (ASX:CMP)
Mar 07We Think Compumedics (ASX:CMP) Has A Fair Chunk Of Debt
Nov 03Is Compumedics (ASX:CMP) A Risky Investment?
May 27Compumedics (ASX:CMP) Could Be At Risk Of Shrinking As A Company
Jan 25Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year
Oct 19Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly
Oct 14Is Compumedics (ASX:CMP) Using Debt Sensibly?
May 02Compumedics (ASX:CMP) May Have Issues Allocating Its Capital
Dec 08Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends
Aug 09Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden
Jun 10Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)
May 06These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively
Feb 25How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?
Dec 01Ventilation des recettes et des dépenses
Comment Compumedics gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
31 Dec 23 | 50 | 1 | 19 | 6 |
30 Sep 23 | 47 | -2 | 19 | 6 |
30 Jun 23 | 43 | -6 | 20 | 5 |
31 Mar 23 | 42 | -6 | 19 | 4 |
31 Dec 22 | 41 | -6 | 19 | 6 |
30 Sep 22 | 40 | -2 | 17 | 5 |
30 Jun 22 | 39 | 1 | 15 | 4 |
31 Mar 22 | 37 | 1 | 15 | 4 |
31 Dec 21 | 34 | 0 | 14 | 5 |
30 Sep 21 | 35 | 0 | 14 | 5 |
30 Jun 21 | 36 | 1 | 14 | 4 |
31 Mar 21 | 35 | -2 | 15 | 4 |
31 Dec 20 | 35 | -5 | 15 | 3 |
30 Sep 20 | 35 | -5 | 15 | 4 |
30 Jun 20 | 35 | -6 | 15 | 4 |
31 Mar 20 | 38 | -1 | 15 | 4 |
31 Dec 19 | 41 | 3 | 15 | 5 |
30 Sep 19 | 41 | 4 | 15 | 5 |
30 Jun 19 | 42 | 4 | 14 | 5 |
31 Mar 19 | 41 | 3 | 14 | 6 |
31 Dec 18 | 40 | 3 | 14 | 6 |
30 Sep 18 | 38 | 3 | 13 | 5 |
30 Jun 18 | 37 | 3 | 13 | 5 |
31 Mar 18 | 36 | 2 | 13 | 5 |
31 Dec 17 | 34 | 2 | 13 | 5 |
30 Sep 17 | 34 | 2 | 13 | 5 |
30 Jun 17 | 34 | 1 | 13 | 6 |
31 Mar 17 | 35 | 1 | 12 | 6 |
31 Dec 16 | 36 | 2 | 12 | 6 |
30 Sep 16 | 37 | 2 | 12 | 6 |
30 Jun 16 | 38 | 3 | 12 | 6 |
31 Mar 16 | 36 | 3 | 12 | 5 |
31 Dec 15 | 35 | 3 | 12 | 4 |
30 Sep 15 | 34 | 2 | 11 | 5 |
30 Jun 15 | 33 | 2 | 11 | 5 |
31 Mar 15 | 33 | 2 | 11 | 5 |
31 Dec 14 | 32 | 1 | 11 | 6 |
30 Sep 14 | 31 | 1 | 11 | 5 |
30 Jun 14 | 31 | 1 | 10 | 5 |
31 Mar 14 | 30 | 0 | 10 | 5 |
31 Dec 13 | 28 | 0 | 10 | 5 |
30 Sep 13 | 28 | -1 | 10 | 5 |
Des revenus de qualité: CMP has a large one-off gain of A$1.7M impacting its last 12 months of financial results to 31st December, 2023.
Augmentation de la marge bénéficiaire: CMP became profitable in the past.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: CMP's earnings have declined by 38.2% per year over the past 5 years.
Accélération de la croissance: CMP has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Bénéfices par rapport au secteur d'activité: CMP has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Rendement des fonds propres
ROE élevé: CMP's Return on Equity (6.8%) is considered low.